Skip to content

Calibrator for automated systems USA standardized 10759350360Recalls & reported problems

Roche Diagnostics GmbH · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04015630936342), received between Oct 30, 2024 and Oct 30, 2024 — classified as 1 malfunction.

The most frequently reported specific device problem is “High Test Results” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 1 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • High Test Results1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionOct 30, 2024High Test Results; High Test Results

    THERE WAS AN ALLEGATION OF QUESTIONABLE CREATININE JAFFÉ GEN. 2 RESULTS FOR APPROXIMATELY 8 PATIENT SAMPLES ON A COBAS INTEGRA 400 PLUS ANALYZER. THE CUSTOMER PROVIDED 3 EXAMPLES. PATIENT 1: THE INITIAL RESULT WAS 2.9 MG/DL AND THE REPEATED RESULT WAS 1.08 MG/DL. PATIENT 2: THE INITIAL RESULT WAS 3.1 MG/DL AND THE REPEATED RESULT WAS 0.86 MG/DL. PATIENT 3: THE INITIAL RESULT WAS 3.1 MG/DL AND THE REPEATED RESULT WAS 0.82 MG/DL. THE QUESTIONABLE RESULTS WERE REPORTED OUTSIDE THE LABORATORY. THE SAMPLES WERE REPEATED BECAUSE CALIBRATION AND QC FAILED. THE REPEATED RESULTS WERE BELIEVED TO BE CORRECT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20569432 ↗

Other CALIBRATOR, MULTI-ANALYTE MIXTURE devices

All CALIBRATOR, MULTI-ANALYTE MIXTURE devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page